Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,501-1,525 of 2,022
CompletedNCT03356639

A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia

This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Astellas Pharma Global Development, Inc.
Condition
Schizophrenia
CompletedNCT01527305

A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China, Malaysia, South Korea, Taiwan
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
CompletedNCT04659174

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Ukraine, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
CompletedNCT01051531

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

This study exists to better understand the safety of the medication Paliperidone and how manageable it feels in practice. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Australia, China, Malaysia, New Zealand, Philippines, South Korea, Taiwan, Thailand
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
CompletedNCT06653829

NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
North Shore Therapeutics, Inc.
Condition
Schizophrenia
Not Yet RecruitingNCT06649214

A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia

This study exists to understand whether the medication Olanzapine-Samidorphan is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication Olanzapine-Samidorphan in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Global
Sponsor
Qilu Pharmaceutical Co., Ltd.
Condition
Schizophrenia
WithdrawnNCT03263533

HDAC Inhibitor Augmentation to Clozapine

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Global
Sponsor
Virginia Commonwealth University
Condition
Schizophrenia
RecruitingNCT06634446

Self-administered COgnitive Personalized Training in Early Psychosis

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Schizophrenia
WithdrawnNCT05584215

Cognitive Behavioural Therapy-Informed Groups for Psychosis

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Global
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition
Schizophrenia
CompletedNCT03669250

CVN058 Effect on Mismatch Negativity in Schizophrenics

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Cerevance Alpha, Inc.
Condition
Schizophrenia
RecruitingNCT06617104

Autonomic Nervous System and Meridian Energy in Patients With Schizophrenia

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand whether questionnaires and follow-up reports can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
National Taiwan University Hospital
Condition
Schizophrenia
CompletedNCT05496413

Investigating the Cognitive Source of Visual Working Memory Impairment in Schizophrenia

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
Taipei Medical University Shuang Ho Hospital
Condition
Schizophrenia
CompletedNCT04001114

Cigarette Smoking in Smokers With and Without Schizophrenia

This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT03525054

Semantic and Syntactic Computerized Analysis of Free Speech

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 15 Years to 30 Years
Countries
France
Sponsor
University Hospital, Brest
Condition
Schizophrenia
Active Not RecruitingNCT04892199

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Denmark
Sponsor
Anders Fink-Jensen, MD, DMSci
Condition
Schizophrenia
TerminatedNCT06134661

Accelerated rTMS for Psychomotor Slowing

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Switzerland
Sponsor
University of Bern
Condition
Schizophrenia
RecruitingNCT03332966

Youth Experiences and Health Study

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

SchizophreniaOtherFrom 15 Years to 18 Years
Countries
Finland
Sponsor
Finnish Institute for Health and Welfare
Condition
Schizophrenia
CompletedNCT06610500

Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
CompletedNCT02685748

Aspirin in Young Psychotic Patients

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 28 Years
Countries
Serbia
Sponsor
Clinic for Psychiatric Disorders, Dr Laza Lazarevic
Condition
Schizophrenia
CompletedNCT06446856

EVEN - Effects of VR on Empathy for Nature in Patients with Psychosis and Depressive Disorders

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Depression